BIT Chart, page-391

I see BIT playing out in one of 3 ways:

1. Phase 3 is successful and BIT 225 does in fact perform consistently as per original tests, BIT commercialises their product, and becomes a multi billion dollar company in their own right, and or gets bought out.

2. BIT presents findings to potential partnership companies as per last ANN, BIT merges or is bought out. At worst BIT 225 is used with existing drugs to "control" HIV, whilst more conclusive testIng Is done, if successful commercialistion is achieved further down the track.

3. BIT finds no partnership companies and is effectively back to a "research" company SP back to 2c